Correction

No authors listed

Published Erratum

No authors listed. Cancer Sci. 2021 May.

. 2021 May;112(5):2064.

doi: 10.1111/cas.14922.

No abstract available

Erratum for

Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY.
Nishio M, Seto T, Reck M, Garon EB, Chiu CH, Yoh K, Imamura F, Park K, Shih JY, Visseren-Grul C, Frimodt-Moller B, Zimmermann A, Homma G, Enatsu S, Nakagawa K; RELAY Study Investigators. Nishio M, et al. Cancer Sci. 2020 Dec;111(12):4510-4525. doi: 10.1111/cas.14655. Epub 2020 Oct 14. Cancer Sci. 2020. PMID: 32954593 Free PMC article. Clinical Trial.

1. Nishio M, Seto T, Reck M, et al. Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY. Cancer Sci. 2020;111:4510–4525. 10.1111/cas.14655. - DOI - PMC - PubMed